These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

277 related items for PubMed ID: 15671276

  • 21. The United Kingdom Infantile Spasms Study (UKISS) comparing hormone treatment with vigabatrin on developmental and epilepsy outcomes to age 14 months: a multicentre randomised trial.
    Lux AL, Edwards SW, Hancock E, Johnson AL, Kennedy CR, Newton RW, O'Callaghan FJ, Verity CM, Osborne JP, United Kingdom Infantile Spasms Study.
    Lancet Neurol; 2005 Nov; 4(11):712-7. PubMed ID: 16239177
    [Abstract] [Full Text] [Related]

  • 22. Balancing clinical benefits of vigabatrin with its associated risk of vision loss.
    Pellock JM.
    Acta Neurol Scand Suppl; 2011 Nov; (192):83-91. PubMed ID: 22061183
    [Abstract] [Full Text] [Related]

  • 23. Treatment of infantile spasms.
    Hancock E, Osborne J, Milner P.
    Cochrane Database Syst Rev; 2003 Nov; (3):CD001770. PubMed ID: 12917912
    [Abstract] [Full Text] [Related]

  • 24. Vigabatrin in the treatment of childhood epilepsy: a retrospective chart review of efficacy and safety profile.
    Camposano SE, Major P, Halpern E, Thiele EA.
    Epilepsia; 2008 Jul; 49(7):1186-91. PubMed ID: 18479386
    [Abstract] [Full Text] [Related]

  • 25. Safety and effectiveness of hormonal treatment versus hormonal treatment with vigabatrin for infantile spasms (ICISS): a randomised, multicentre, open-label trial.
    O'Callaghan FJ, Edwards SW, Alber FD, Hancock E, Johnson AL, Kennedy CR, Likeman M, Lux AL, Mackay M, Mallick AA, Newton RW, Nolan M, Pressler R, Rating D, Schmitt B, Verity CM, Osborne JP, participating investigators.
    Lancet Neurol; 2017 Jan; 16(1):33-42. PubMed ID: 27838190
    [Abstract] [Full Text] [Related]

  • 26. Vigabatrin therapy in infantile spasms: solving one problem and inducing another?
    Wohlrab G, Leiba H, Kästle R, Ramelli G, Schmitt-Mechelke T, Schmitt B, Landau K.
    Epilepsia; 2009 Aug; 50(8):2006-8. PubMed ID: 19682036
    [No Abstract] [Full Text] [Related]

  • 27. Treatment of infantile spasms.
    Hancock EC, Osborne JP, Edwards SW.
    Cochrane Database Syst Rev; 2013 Jun 05; 2013(6):CD001770. PubMed ID: 23740534
    [Abstract] [Full Text] [Related]

  • 28. Infantile spasms as a cause of acquired perinatal visual loss.
    Brooks BP, Simpson JL, Leber SM, Robertson PL, Archer SM.
    J AAPOS; 2002 Dec 05; 6(6):385-8. PubMed ID: 12506281
    [Abstract] [Full Text] [Related]

  • 29. Favourable prognostic factors with infantile spasms.
    Riikonen RS.
    Eur J Paediatr Neurol; 2010 Jan 05; 14(1):13-8. PubMed ID: 19362867
    [Abstract] [Full Text] [Related]

  • 30. Cortical visual impairment in children with infantile spasms.
    Castano G, Lyons CJ, Jan JE, Connolly M.
    J AAPOS; 2000 Jun 05; 4(3):175-8. PubMed ID: 10849395
    [Abstract] [Full Text] [Related]

  • 31. Vigabatrin administration in patients with infantile spasms: the risks.
    Jaseja H.
    Clin Neurol Neurosurg; 2010 Nov 05; 112(9):835. PubMed ID: 20934097
    [No Abstract] [Full Text] [Related]

  • 32. Steroids or vigabatrin in the treatment of infantile spasms?
    Riikonen RS.
    Pediatr Neurol; 2000 Nov 05; 23(5):403-8. PubMed ID: 11118795
    [Abstract] [Full Text] [Related]

  • 33. Vigabatrin in the treatment of infantile spasms in tuberous sclerosis: literature review.
    Hancock E, Osborne JP.
    J Child Neurol; 1999 Feb 05; 14(2):71-4. PubMed ID: 10073425
    [Abstract] [Full Text] [Related]

  • 34. Vigabatrin in infantile spasms: preliminary result.
    Visudtibhan A, Chiemchanya S, Visudhiphan P, Phusirimongkol S.
    J Med Assoc Thai; 1999 Oct 05; 82(10):1000-5. PubMed ID: 10561962
    [Abstract] [Full Text] [Related]

  • 35. Changes in the ERG d-wave with vigabatrin treatment in a pediatric cohort.
    Dragas R, Westall C, Wright T.
    Doc Ophthalmol; 2014 Oct 05; 129(2):97-104. PubMed ID: 25008578
    [Abstract] [Full Text] [Related]

  • 36. Practice parameter: medical treatment of infantile spasms: report of the American Academy of Neurology and the Child Neurology Society.
    Mackay MT, Weiss SK, Adams-Webber T, Ashwal S, Stephens D, Ballaban-Gill K, Baram TZ, Duchowny M, Hirtz D, Pellock JM, Shields WD, Shinnar S, Wyllie E, Snead OC, American Academy of Neurology, Child Neurology Society.
    Neurology; 2004 May 25; 62(10):1668-81. PubMed ID: 15159460
    [Abstract] [Full Text] [Related]

  • 37. Vigabatrin monotherapy for infantile spasms.
    Gaily E.
    Expert Rev Neurother; 2012 Mar 25; 12(3):275-86. PubMed ID: 22364326
    [Abstract] [Full Text] [Related]

  • 38. Vigabatrin therapy for infantile spasms: review of major trials in Europe, Canada, and the United States; and recommendations for dosing.
    Carmant L.
    Acta Neurol Scand Suppl; 2011 Mar 25; (192):36-47. PubMed ID: 22061179
    [Abstract] [Full Text] [Related]

  • 39. The latest on infantile spasms.
    Riikonen R.
    Curr Opin Neurol; 2005 Apr 25; 18(2):91-5. PubMed ID: 15791136
    [Abstract] [Full Text] [Related]

  • 40. Response to second treatment after initial failed treatment in a multicenter prospective infantile spasms cohort.
    Knupp KG, Leister E, Coryell J, Nickels KC, Ryan N, Juarez-Colunga E, Gaillard WD, Mytinger JR, Berg AT, Millichap J, Nordli DR, Joshi S, Shellhaas RA, Loddenkemper T, Dlugos D, Wirrell E, Sullivan J, Hartman AL, Kossoff EH, Grinspan ZM, Hamikawa L, Pediatric Epilepsy Research Consortium.
    Epilepsia; 2016 Nov 25; 57(11):1834-1842. PubMed ID: 27615012
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 14.